Search by Drug Name or NDC

    NDC 68180-0215-06 Losartan Potassium and Hydrochlorothiazide 12.5; 50 mg/1; mg/1 Details

    Losartan Potassium and Hydrochlorothiazide 12.5; 50 mg/1; mg/1

    Losartan Potassium and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM.

    Product Information

    NDC 68180-0215
    Product ID 68180-215_69e6f6ca-f561-4079-8cb6-37cef1ab50b7
    Associated GPIs 36994002450320
    GCN Sequence Number 023465
    GCN Sequence Number Description losartan/hydrochlorothiazide TABLET 50-12.5 MG ORAL
    HIC3 A4I
    HIC3 Description ANGIOTENSIN RECEPTOR ANTAG.-THIAZIDE DIURETIC COMB
    GCN 14852
    HICL Sequence Number 009863
    HICL Sequence Number Description LOSARTAN POTASSIUM/HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name Losartan Potassium and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Losartan Potassium and Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 12.5; 50
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078245
    Listing Certified Through 2024-12-31

    Package

    NDC 68180-0215-06 (68180021506)

    NDC Package Code 68180-215-06
    Billing NDC 68180021506
    Package 30 TABLET in 1 BOTTLE (68180-215-06)
    Marketing Start Date 2010-10-06
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.12253
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis